AtriCure - About the company
AtriCure is a public company based in Mason (United States), founded in 2000. It operates as a Medical device company focused on atrial fibrillation and pain management. The company has 71 active competitors, including 23 funded and 21 that have exited. Its top competitors include companies like AtaCor Medical, EBR Systems and CardioFocus.
Company Details
Medical device company focused on atrial fibrillation and pain management. They offer therapies and procedures for healthcare professionals, including surgical ablation, hybrid AF therapy, left atrial appendage management, and cryo nerve block therapy. Their products include ablation systems, cryoablation probes, access devices, and minimally invasive surgical instruments. They provide education and training programs, clinical evidence, and resources for patients and caregivers related to atrial fibrillation and cryo nerve block. They are committed to environmental, social, and governance responsibilities, focusing on sustainability, patient care, employee empowerment, and partner collaboration. They innovate devices that directly support patient care and recovery.
- Website
- atricure.com
Key Metrics
Founded Year
2000
Location
Mason, United States
Stage
Public
Investors
Ranked
3rd among 71 active competitors
Annual Revenue
$500M - $1B as on Dec 31, 2025
Employee Count
1,386 as on Aug 31, 2026
Investment & Acquisitions
Similar Companies
Exit Details
Public
Legal entities associated with AtriCure
AtriCure is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Atricure, Inc. CIN: 610797272 , Australia, Active | Feb 16, 2016 | - | - | |
Atricure, Inc CIN: 34-1940305 , United States, Active | - | 1200 (As on Dec 31, 2023) | - | |
Atricure, Inc. CIN: 1323885 , United States, Active | Oct 30, 2000 | $500M - $1B (As on Dec 31, 2025) | 824 (As on Dec 31, 2022) | - |
AtriCure's IPO details
AtriCure got listed on Aug 05, 2005.
Click here to take a look at AtriCure's IPO in detail
Sign up to download AtriCure's company profile
AtriCure's funding and investors
AtriCure is a funded company. AtriCure has 4 institutional investors.
View details of AtriCure's funding rounds and investors
AtriCure's founders and board of directors
Founder? Claim ProfileAtriCure's employee count trend
AtriCure has 1,386 employees as of Aug 26. Here is AtriCure's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
AtriCure's Competitors and alternates
Top competitors of AtriCure include AtaCor Medical, EBR Systems and CardioFocus. Here is the list of Top 10 competitors of AtriCure, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AtaCor Medical 2014, San Clemente (United States), Series D | Transforming cardiac rhythm management with innovative extravascular pacing and defibrillation solutions | $137M | 64/100 | |
2nd | EBR Systems 2003, Sunnyvale (United States), Public | Revolutionizing cardiac rhythm management with leadless pacing technology for heart failure | $180M | 60/100 | |
3rd | AtriCure 2000, Mason (United States), Public | Medical device company focused on atrial fibrillation and pain management | - | 59/100 | |
4th | CardioFocus 1990, Marlborough (United States), Series E | Endoscopically guided catheter for ablation | $261M | 58/100 | |
5th | CathVision 2013, Copenhagen (Denmark), Series B | Provider and developer of an AI-based cardiac ablation therapy software and device | $36.1M | 57/100 | |
6th | Kestra Medical Technologies 2014, Kirkland (United States), Public | Device to protect and support patients at risk of cardiovascular disorders | $196M | 54/100 | |
7th | TyRx 1998, Monmouth Junction (United States), Acquired | Antibacterial envelopes for cardiac implants | $70.8M | 47/100 | |
8th | Cameron Health 2001, San Clemente (United States), Acqui-Hired | Subcutaneous Implantable Defibrillator | $158M | 45/100 | |
9th | nContact Surgical 2005, Morrisville (United States), Acquired | Cardiac ablation technology | $53.2M | 45/100 | |
10th | Append Medical 2016, Or Yehuda (Israel), Series A | Developer of a device for the left atrial appendage closure system | $11.8M | 45/100 |
Looking for more details on AtriCure's competitors? Click here to see the top ones
AtriCure's Investments and acquisitions
AtriCure has not made any investments yet. AtriCure has made 5 acquisitions.Here is the list of latest three $acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Aug 12, 2019 | Acquisition | 2005 | Redwood City (United States) | |
Oct 05, 2015 | Acquisition | 2005 | Morrisville (United States) | |
Oct 04, 2015 | Acquisition | 2010 | - |
See all acquisitions by AtriCure
Reports related to AtriCure
Here is the latest report on AtriCure's sector:
News related to AtriCure
Media has covered AtriCure for a total of 13 events in the last 1 year, 7 of them have been about company updates.
•
•
•
•
Oak Harvest Investment Services Makes New $1.48 Million Investment in AtriCure, Inc.MarketBeat•Apr 18, 2026•Oak Harvest FG, AtriCure, BlackRock
•
AtriCure, Inc. $ATRC Position Reduced by GW&K Investment Management LLCMarketBeat•Mar 06, 2026•GW&K, AtriCure
•
AtriCure Reports Fourth Quarter 2025 and Full Year 2025 Financial ResultsBusiness Wire•Feb 18, 2026•AtriCure
•
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026Business Wire•Jan 12, 2026•AtriCure
•
Squarepoint Ops LLC Acquires 350,771 Shares of Cal-Maine Foods, Inc. $CALMMarketBeat•Dec 12, 2025•Squarepoint Capital, Cal-Maine Foods, AtriCure, Xencor
•
AtriCure Announces the First Patients Treated with Novel Dual Energy PlatformBusiness Wire•Dec 11, 2025•AtriCure
•
Connor Clark & Lunn Investment Management Ltd. Raises Holdings in AtriCure, Inc. $ATRCMarketBeat•Nov 14, 2025•Connor, Clark & Lunn Financial Group, AtriCure, NU Skin
Are you a Founder ?
FAQs about AtriCure
Explore our recently published companies
- Ascan Tesdorpf Architect - Germany based, 1995 founded, Unfunded company
- ARCHIBALD - France based, 2012 founded, Unfunded company
- APN - Los Angeles based, Unfunded company
- Apartment Locators of Tucson - Tucson based, Public company
- ANTREEM - Italy based, 2012 founded, Unfunded company
- Allegra Consulting - Melbourne based, 2005 founded, Unfunded company
